(RTTNews) - BioLineRx Ltd. (BLRX), a clinical-stage biopharmaceutical company, announced on Friday that updated results from the pilot phase of its Phase 2 CheMo4METPANC trial demonstrated promising ...
First safety analysis of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with oxaliplatin ...
Efficacy and safety of nimotuzumab plus AG regimen as conversion therapy for locally advanced pancreatic cancer: A prospective, single-arm study. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results